SCHEMBL20127449

SCHEMBL20127449

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6c7ccccc7c7ccccc7c6c5)cc4)c4ccccc34)c3oc4ccccc4c3cc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.37
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
ALOX5 P09917 2/20 0.35
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
PIK3CD O00329 2/20 0.34
XRCC6 P12956 2/20 0.34
XRCC5 P13010 2/20 0.34
PRKDC P78527 2/20 0.34
PIK3CA P42336 1/20 0.34
PGR P06401 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
CASP3 P42574 1/20 0.32
SENP7 Q9BQF6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127432 0.94 ALOX5 (0.40) AHRPLA2G2APLA2G4AALOX5PIK3CD
SCHEMBL20127456 0.92 PLA2G2A (0.38) AHRPLA2G2APLA2G4AALOX5PIK3CD
SCHEMBL20127462 0.92 MAPT (0.40) AHRPLA2G2APLA2G4AALOX5PIK3CD
SCHEMBL10122554 0.90 PIK3CD (0.41) AHRPLA2G2APLA2G4AALOX5ESR1
SCHEMBL10122576 0.89 GPR84 (0.39) AHRPLA2G2APLA2G4AALOX5ESR1
SCHEMBL20127650 0.89 AHR (0.41) AHRPLA2G2APLA2G4AALOX5PGR
SCHEMBL10122561 0.87 PIK3CD (0.42) AHRPLA2G2APLA2G4AALOX5ESR1
SCHEMBL20906794 0.87 AHR (0.44) AHRPLA2G2APLA2G4AALOX5ESR1
SCHEMBL20127450 0.86 ALOX5 (0.38) AHRALOX5ESR1ESR2PIK3CD
SCHEMBL10122675 0.86 PIK3CD (0.41) AHRPLA2G2APLA2G4AALOX5ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 AHR 2558/4885PLA2G2A 2960/4885PLA2G4A 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.